Armolipid Plus food supplement

Armolipid Plus is a widely recognized dietary supplement designed to support cardiovascular health and manage cholesterol levels. The brand was originally developed in Italy by Meda Pharma, a company with deep roots in the European pharmaceutical sector.

Starting from 1999, the product gained popularity for its formulation involving red yeast rice and berberine. In 2016, Mylan acquired Meda Pharma, and subsequently, in 2020, Mylan merged with Upjohn (a division of Pfizer) to form Viatris. Today, Armolipid remains a key product within the Viatris portfolio, primarily manufactured in Italy to serve the European market and beyond. The brand represents a bridge between traditional herbal extracts and modern pharmaceutical standards.